A shortage of Danish drugmaker Novo Nordisk's popular weight-loss and diabetes drugs, Wegovy and Ozempic, has been resolved, the U.S. Food and Drug Administration's website showed on Friday.

On The Readout LOUD this week, STAT reporters discuss the FDA's staff cuts, how next-gen drugs may lead to too much weight loss, and zombie biotech firms.

A bipartisan group of U.S. state and territory attorneys general is pressing the FDA to take prompt action against those threatening public health by marketing counterfeit forms of branded weight loss medications developed by Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY).

A list with the file name "Prohibited words" has been circulating since at least last week in official work chats, according to two FDA scientists with direct knowledge of the matter.

Food and Drug Administration staffers were told not to use words like “woman” and “disabled” in work chats for at least the last week, but the White House said this order was erroneous. A White House spokesperson told Reuters that the list of “prohibited words” came from a misunderstanding of President Donald Trump’s executive orders

Scientists at the Food and Drug Administration say they were told to stop using certain words in external communications, including “woman,” “disabled,” and “elderly,” according to a report. Two FDA scientists told Reuters that a file titled “Prohibited Words” showing a list of banned terms was circulated at the agency over the last week.